More drugmakers including Gilead, Biogen, BMS to hike US prices for 50 drugs Medical Dialogues Bureau2 Jan 2020 2:48 PM ISTNew Delhi: Drugmakers including Bristol-Myers Squibb Co (BMY.N), Gilead Sciences Inc (GILD.O), and Biogen Inc (BIIB.O) hiked U.S. list prices on more...
Trump administration scraps key plan to reduce US drug prices Medical Dialogues Bureau12 July 2019 9:00 AM ISTThe decision represents a new setback to U.S. President Donald Trump's efforts to deliver on a pledge to lower drug prices for consumers before the...
Abbvie finalizes deal to buy Botox maker Allergan for $63 billion Medical Dialogues Bureau26 Jun 2019 10:00 AM ISTA note from Moody's affirmed Abbvie's debt rating, saying a plan to reduce debt through existing blockbusters like AbbVie's Humira and Imbruvica and...
Trump to keep fighting opioids 'until our job is done' Medical Dialogues Bureau28 April 2019 9:00 AM ISTWhile prescription opioids initially accounted for most deaths, the epidemic is now driven by illicit heroin and fentanyl.ATLANTA: President Donald...
Medicare hospital fund reserves likely to be exhausted in 2026: US report Medical Dialogues Bureau23 April 2019 9:00 AM ISTThe report from the board of trustees for Social Security and Medicare also projected that Social Security funds could be depleted by 2035, leading to...
Skeptical Democrats to quiz Trump health pick on drug prices Ruby Khatun Khatun1 Dec 2017 9:15 AM ISTWASHINGTON: Skeptical Democratic senators are getting a chance to question President Donald Trump's pick for health secretary about what he'll do...
